drugset / Trial / NCT03904316

Use of Biodesign® Otologic Graft in Tympanoplasty

NCT03904316 ↗

Phase 4 Withdrawn Henry Ford Health System
RandomizedParallel-groupOpen-labelTreatment

Summary

This is a prospective, randomized trial to evaluate tympanoplasty outcomes using Biodesign SIS graft compared to autologous temporalis fascia, the most commonly used graft for repair of tympanic membrane.

Timeline

Start
2018-10-03
Primary completion
2022-07-01
Completion
2022-07-01

Outcome

Outcome not reported

Stopped: “The trial was stopped as the benefit was challenging to determine in preliminary usage.”

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Biodesign Otologic graft Other / unclassified — —